ArticleOncology letters2019

Oxaliplatin reverses the GLP-1R-mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signaling.

Bendong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.